Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2020

Feb 8, 2020

30237_dirs_2020-02-07_7e0c5bcb-286d-4fc7-b5b3-8eb5f71b1cb5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-02-04

Reporting Person: van der Vaart Sandra D (SVP, Global General Counsel)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-04 Restricted Stock Unit $ A 900 Acquired Common Stock (900) Direct
2020-02-04 Non-qualified Stock Options $182.51 A 3900 Acquired 2030-02-03 Common Stock (3900) Direct

Footnotes

F1: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: This amended form is filed to update the number of Employee Stock Options and Restricted Stock Units awarded and set for on Table II.

F3: The Restricted Stock Units vest in three equal annual installments beginning on February 4, 2021.

F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

F5: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.

F6: The option vests in three equal annual installments beginning on the date reflected in this column.